These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27076188)

  • 21. The importance of age in allocating health care resources: does intervention-type matter?
    Johri M; Damschroder LJ; Zikmund-Fisher BJ; Ubel PA
    Health Econ; 2005 Jul; 14(7):669-78. PubMed ID: 15497189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG
    World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What reasons do those with practical experience use in deciding on priorities for healthcare resources? A qualitative study.
    Hasman A; McIntosh E; Hope T
    J Med Ethics; 2008 Sep; 34(9):658-63. PubMed ID: 18757635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Life-saving treatments and disabilities. Are all QALYs created equal?
    Ubel PA; Richardson J; Prades JL
    Int J Technol Assess Health Care; 1999; 15(4):738-48. PubMed ID: 10645115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Priority setting for health interventions in Mexico's System of Social Protection in Health].
    González-Pier E; Gutiérrez-Delgado C; Stevens G; Barraza-Lloréns M; Porras-Condey R; Carvalho N; Loncich K; Dias RH; Kulkarni S; Casey A; Murakami Y; Ezzati M; Salomon JA
    Salud Publica Mex; 2007; 49 Suppl 1():S37-52. PubMed ID: 17469398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity analysis in summary measure of population health in France.
    Lapostolle A; Lefranc A; Gremy I; Spira A
    Eur J Public Health; 2008 Apr; 18(2):195-200. PubMed ID: 18037621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Death: a foe to be conquered? Questioning the paradigm.
    Gellie A; Mills A; Levinson M; Stephenson G; Flynn E
    Age Ageing; 2015 Jan; 44(1):7-10. PubMed ID: 25225350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Years of potential life lost and valued years of potential life lost in assessing premature mortality in Slovenia.
    Semerl JS; Sesok J
    Croat Med J; 2002 Aug; 43(4):439-45. PubMed ID: 12187522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Russian translations for Cochrane.
    Yudina EV; Ziganshina LE
    Int J Risk Saf Med; 2015; 27 Suppl 1():S112-3. PubMed ID: 26639688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes toward neonatal intensive care treatment of preterm infants with a high risk of developing long-term disabilities.
    Lam HS; Wong SP; Liu FY; Wong HL; Fok TF; Ng PC
    Pediatrics; 2009 Jun; 123(6):1501-8. PubMed ID: 19482760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Life extension research: health, illness, and death.
    Turner L
    Health Care Anal; 2004 Jun; 12(2):117-29. PubMed ID: 15487814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Priority setting and implementation in a centralized health system: a case study of Kerman province in Iran.
    Khayatzadeh-Mahani A; Fotaki M; Harvey G
    Health Policy Plan; 2013 Aug; 28(5):480-94. PubMed ID: 23002248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Making the case for human life extension: personal arguments.
    Schloendorn J
    Bioethics; 2006 Aug; 20(4):191-202. PubMed ID: 17044153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Priority setting in guideline development: article 2 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Atkins D; Perez-Padilla R; Macnee W; Buist AS; Cruz AA;
    Proc Am Thorac Soc; 2012 Dec; 9(5):225-8. PubMed ID: 23256163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Miscarriage, Abortion, and Disease.
    Waters T
    J Med Philos; 2023 May; 48(3):243-251. PubMed ID: 37078977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The concepts of health and illness revisited.
    Nordenfelt L
    Med Health Care Philos; 2007 Mar; 10(1):5-10. PubMed ID: 16955344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.